These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 191408)

  • 1. Lymphocyte responses to EBV-associated antigens in infectious mononucleosis, and Hodgkin's and non-Hodgkin's lymphoma patients, with the leukocyte adherence inhibition assay.
    Chan SH; Wallen WC; Levine PH; Periman P; Perlin E
    Int J Cancer; 1977 Mar; 19(3):356-63. PubMed ID: 191408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IgA to Epstein-Barr virus early antigen-diffuse identifies Hodgkin's lymphoma.
    McAllister SC; Shedd D; Mueller NE; Chang ET; Miller G; Bhaduri-McIntosh S
    J Med Virol; 2014 Sep; 86(9):1621-8. PubMed ID: 24122847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
    Periman P; Levine PH; Ablashi DV; Royston I
    Int J Cancer; 1977 Oct; 20(4):506-11. PubMed ID: 199544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
    Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE
    Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
    Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang JS; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
    N Engl J Med; 2003 Oct; 349(14):1324-32. PubMed ID: 14523140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.
    Reynolds DJ; Banks PM; Gulley ML
    Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.
    Band PR; Levine PH; Patwardhan VC; Shnitka TK; Pabst HF
    Can Med Assoc J; 1973 Jan; 108(2):183-6. PubMed ID: 4346314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV antigens in lymphocytes of patients with exudative tonsillitis, infectious mononucleosis and Hodgkin's disease.
    Veltri RW; McClung JE; Sprinkle PM
    Int J Cancer; 1978 Jun; 21(6):683-7. PubMed ID: 78913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Epstein-Barr virus-coded antigens in lymphocytes isolated from defined patient samples.
    Veltri RW; McClung JE; Sprinkle PM
    IARC Sci Publ (1971); 1978; (24 Pt 2):729-32. PubMed ID: 221395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of migration inhibitory factor (MIF) by human leukocytes following exposure to Epstein-Barr virus.
    Wilson GL; Young BG
    Cell Immunol; 1978 Jun; 38(1):147-56. PubMed ID: 208782
    [No Abstract]   [Full Text] [Related]  

  • 12. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
    Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
    IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-related serology in Hodgkin's disease.
    Henle W; Henle G
    Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
    [No Abstract]   [Full Text] [Related]  

  • 15. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
    Levine PH; Reisher JI
    Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
    [No Abstract]   [Full Text] [Related]  

  • 17. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings.
    Evans AS; Gutensohn NM
    Int J Cancer; 1984 Aug; 34(2):149-57. PubMed ID: 6088401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease.
    Lange B; Arbeter A; Hewetson J; Henle W
    Int J Cancer; 1978 Nov; 22(5):521-7. PubMed ID: 82539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease.
    Khan G; Naase MA
    J Clin Pathol; 1995 Sep; 48(9):845-8. PubMed ID: 7490319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus, fatal infectious mononucleosis, and Hodgkin's disease in siblings.
    Veltri RW; Shah SH; McClung JE; Klingberg WG; Sprinkle PM
    Cancer; 1983 Feb; 51(3):509-20. PubMed ID: 6295604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.